ALK and cancer: Moreover, our hypothesis considered the possibility of redirecting TAMs activity against ALK-positive tumors, particularly through the restoration of phagocytosis of cancer cells with CD47.DEMs blockade, which would eventually prime CTL through the presentation of ALK peptides [37].